Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
61.918,72
1,69%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Crism Therapeutics Corporation (CRTX) Crism Therapeutics Corporation (CRTX) Notizie

CRTX

Crism Therapeutics (CRTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:CRTX
DataOraFonteTitoloSimboloCompagnia
03/06/202416:25RNS Regulatory NewsCrism Therapeutics Corporation Director DealingLSE:CRTXCrism Therapeutics Corporation
31/05/202422:58Alliance NewsAlliance NewsIN BRIEF: Crism has first day of trade on AIM after name change, buyLSE:CRTXCrism Therapeutics Corporation
31/05/202408:00RNS Regulatory NewsCrism Therapeutics Corporation Admission to Trading and First Day of DealingsLSE:CRTXCrism Therapeutics Corporation
18/12/200919:45PR Newswire (US)Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010NASDAQ:CRTX
20/11/200921:40PR Newswire (US)Cornerstone Therapeutics Provides a Response to FDA Warning Letter on DeconsalNASDAQ:CRTX
16/11/200914:00PR Newswire (US)Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare ConferenceNASDAQ:CRTX
13/11/200914:00PR Newswire (US)Cornerstone Therapeutics Appoints General CounselNASDAQ:CRTX
04/11/200913:00PR Newswire (US)Cornerstone Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:CRTX
21/10/200914:00PR Newswire (US)Cornerstone Therapeutics to Host Third Quarter 2009 Conference CallNASDAQ:CRTX
03/09/200914:01PR Newswire (US)Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)NASDAQ:CRTX
03/09/200914:00PR Newswire (US)Cornerstone Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:CRTX
20/07/200914:00PR Newswire (US)Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business JournalNASDAQ:CRTX
16/07/200901:04PR Newswire (US)Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive ProductNASDAQ:CRTX
08/07/200922:15PR Newswire (US)Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect tNASDAQ:CRTX
12/06/200922:35Dow Jones NewsUPDATE:FDA Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
12/06/200921:28Dow Jones NewsFDA: Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
19/05/200922:01PR Newswire (US)Cornerstone Therapeutics Announces Management ChangeNASDAQ:CRTX
07/05/200913:01PR Newswire (US)Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpANASDAQ:CRTX
07/05/200913:00PR Newswire (US)Cornerstone Therapeutics Reports First Quarter 2009 Financial ResultsNASDAQ:CRTX
27/04/200914:00PR Newswire (US)Cornerstone Therapeutics to Host First Quarter 2009 Conference CallNASDAQ:CRTX
13/01/200923:33Dow Jones NewsUPDATE: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
13/01/200921:34Dow Jones NewsFDA: Singular, Zyflo Asthma Drug Safety Review ContinuesNASDAQ:CRTXCornerstone Therapeutics Inc.
05/11/200814:00PR Newswire (US)Cornerstone Therapeutics Announces New Board of DirectorsNASDAQ:CRTX
01/08/200616:00PR Newswire (US)Critical Therapeutics Files Controlled Release Formulation of ZileutonNASDAQ:CRTX
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:CRTX

La tua Cronologia

BIT
NSCIT5436695
Republic of Italy
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network